![Brian Hilberdink](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Hilberdink formerly worked at BIOTECanada, as Director, Novo Nordisk Canada, Inc., as President, and Leo Pharma, Inc., as President & Executive Vice President from 2022 to 2025.
Mr. Hilberdink received his undergraduate degree from Queen's University.
| Companies | Position | End |
|---|---|---|
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | President | 2025-02-10 |
Novo Nordisk Canada, Inc.
 Novo Nordisk Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | President | - |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | Retail Trade |
Novo Nordisk Canada, Inc.
Novo Nordisk Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
